Human medicines European public assessment report (EPAR): BroPair Spiromax, salmeterol,fluticasone propionate, Date of authorisation: 26/03/2021, Revision: 4, Status: Authorised

Orphan designation: Taladegib Treatment of idiopathic pulmonary fibrosis, 22/05/2025 Positive

Orphan designation: 1-{4-[2-(5-ethoxymethyl-2-methyl-phenylamino)-oxazol-5-yl]-phenyl}-imidazolidin-2-one Treatment of acute myeloid leukaemia, 22/05/2025 Positive

Ursodeoxycholic acid product-specific bioequivalence guidance

Prasugrel product-specific bioequivalence guidance

Paracetamol product-specific bioequivalence guidance

Oseltamivir product-specific bioequivalence guidance

Metformin product-specific bioequivalence guidance

Dabigatran etexilate product-specific bioequivalence guidance

Annual activity report 2024